U1-70K is an important protein component of U1 snRNP that supports the early stages of spliceosome assembly and 5′ splice-site recognition. Explore its structure, interactions, role in RNA splicing, and relevance to abnormal splicing.
U1 snRNA is the RNA component of U1 snRNP and plays a key role in recognizing the 5′ splice site during pre-mRNA splicing. Explore its structure, sequence, RNA-RNA base pairing, spliceosome function, and role in alternative splicing.
U1 snRNP is an early component of the spliceosome that recognizes the 5′ splice site of pre-mRNA. Learn how U1 snRNA and associated proteins help initiate spliceosome assembly, regulate splice-site selection, and support accurate RNA splicing.
The 5′ splice site, also called the donor splice site, marks the beginning of an intron and helps U1 snRNP recognize the correct RNA-splicing boundary. Learn how it works with the spliceosome, branch point, and 3′ splice site during intron removal.
U2AF is an important RNA-splicing factor that helps recognize the 3′ end of many introns. Learn how U2AF65 and U2AF35 interact with the polypyrimidine tract and 3′ splice site and help coordinate spliceosome assembly during pre-mRNA processing.
The polypyrimidine tract is a U- and C-rich sequence near the 3′ end of many introns that helps the spliceosome recognize the 3′ splice site. Learn how it works with the branch point, splicing factors, and other RNA signals to regulate RNA splicing and gene expression.
The branch point is a key sequence region within an intron that contains an important adenosine used during the first reaction of RNA splicing. It helps the spliceosome form the intron lariat and accurately remove introns from pre-mRNA.
Splice sites are RNA sequence signals that guide the spliceosome during intron removal and exon joining. Learn about 5′ and 3′ splice sites, branch points, splicing factors, mutations, and alternative splicing.
Splicing factors are proteins that regulate RNA splicing by influencing splice-site selection and spliceosome activity. Learn how they control alternative splicing, gene expression, development, and disease.
The spliceosome is a complex molecular machine that removes introns and joins exons during RNA splicing. Learn about its components, assembly, function, alternative splicing, gene regulation, mutations, and role in disease.
RNA splicing removes introns from pre-mRNA and joins exons to produce mature RNA. Learn how the spliceosome controls this process and why RNA splicing is essential for gene expression, protein production, and cellular function.
Introns are regions of genes that are transcribed into pre-mRNA but are usually removed during RNA splicing. Learn how introns differ from exons and how they influence gene expression, alternative splicing, and genetic disease.
Alternative splicing allows cells to produce multiple RNA transcripts and protein isoforms from a single gene. Learn how exon skipping, alternative splice sites, splicing factors, and the spliceosome regulate gene expression and contribute to development, disease, and therapeutic applications.
U1-70K is an important protein component of U1 snRNP that supports the early stages of spliceosome assembly and 5′ splice-site recognition. Explore its structure, interactions, role in RNA splicing, and relevance to abnormal splicing.
U1 snRNA is the RNA component of U1 snRNP and plays a key role in recognizing the 5′ splice site during pre-mRNA splicing. Explore its structure, sequence, RNA-RNA base pairing, spliceosome function, and role in alternative splicing.
U1 snRNP is an early component of the spliceosome that recognizes the 5′ splice site of pre-mRNA. Learn how U1 snRNA and associated proteins help initiate spliceosome assembly, regulate splice-site selection, and support accurate RNA splicing.
The 5′ splice site, also called the donor splice site, marks the beginning of an intron and helps U1 snRNP recognize the correct RNA-splicing boundary. Learn how it works with the spliceosome, branch point, and 3′ splice site during intron removal.
U2AF is an important RNA-splicing factor that helps recognize the 3′ end of many introns. Learn how U2AF65 and U2AF35 interact with the polypyrimidine tract and 3′ splice site and help coordinate spliceosome assembly during pre-mRNA processing.
The polypyrimidine tract is a U- and C-rich sequence near the 3′ end of many introns that helps the spliceosome recognize the 3′ splice site. Learn how it works with the branch point, splicing factors, and other RNA signals to regulate RNA splicing and gene expression.
The branch point is a key sequence region within an intron that contains an important adenosine used during the first reaction of RNA splicing. It helps the spliceosome form the intron lariat and accurately remove introns from pre-mRNA.
Splice sites are RNA sequence signals that guide the spliceosome during intron removal and exon joining. Learn about 5′ and 3′ splice sites, branch points, splicing factors, mutations, and alternative splicing.
Splicing factors are proteins that regulate RNA splicing by influencing splice-site selection and spliceosome activity. Learn how they control alternative splicing, gene expression, development, and disease.
The spliceosome is a complex molecular machine that removes introns and joins exons during RNA splicing. Learn about its components, assembly, function, alternative splicing, gene regulation, mutations, and role in disease.
RNA splicing removes introns from pre-mRNA and joins exons to produce mature RNA. Learn how the spliceosome controls this process and why RNA splicing is essential for gene expression, protein production, and cellular function.
Introns are regions of genes that are transcribed into pre-mRNA but are usually removed during RNA splicing. Learn how introns differ from exons and how they influence gene expression, alternative splicing, and genetic disease.
Alternative splicing allows cells to produce multiple RNA transcripts and protein isoforms from a single gene. Learn how exon skipping, alternative splice sites, splicing factors, and the spliceosome regulate gene expression and contribute to development, disease, and therapeutic applications.